Pharmacists in Ewing, New Jersey


30 Pharmacists found in Ewing
male pharmacist

Mr. Manan S Vaghela, RPH,MS


Pharmacist
970 Parkway Ave, Ewing, NJ 08618
609-882-3456    

female pharmacist

Meghaben Dhirubhai Patel, M.S.P'COLOGY/TOXICO


Pharmacist
970 Parkway Ave, Ewing, NJ 08618
609-882-3456     609-882-4461

female pharmacist

Puja Amin


Pharmacist
1700 N Olden Ave, Ewing, NJ 08638
609-896-9089    



male pharmacist

Richard Kozlowski, RPH


Pharmacist
1750 N Olden Ave, Ewing, NJ 08638
609-219-0076     609-219-0655

male pharmacist

Dr. Sarung M Modi, PHARM.D.


Pharmacist
970 Parkway Ave, Ewing, NJ 08618
609-882-3456    

male pharmacist

Dr. Scott Jaffe, D.C., RPH.



1750 N Olden Ave, Ewing, NJ 08638
609-219-0076     609-219-0655

female pharmacist

Seema R Jamal, RPH


Pharmacist
1400 Parkway Ave Ste A2, Ewing, NJ 08628
609-323-7503    

female pharmacist

Stephanie Eng


Pharmacist
970 Parkway Ave, Ewing, NJ 08618
609-882-3456    

male pharmacist

Dr. Umair S Ahmad, PHARMD


Pharmacist
1320 Parkway Ave, Ewing, NJ 08628
609-882-4097    

female pharmacist

Mrs. Urvashi Patel, RPH


Pharmacist
1750 N Olden Ave, Ewing, NJ 08638
609-219-0076    

female pharmacist

Urvashi Sharma


Pharmacist
1801 N Olden Ave, Ewing, NJ 08638
609-493-9902    

female pharmacist

Vasumathi Molugu


Pharmacist
1700 N Olden Ave, Ewing, NJ 08638
609-989-1400    

male pharmacist

Mr. Vikram R Patel, RPH


Pharmacist
1750 N Olden Ave, Ewing, NJ 08638
609-219-0076     609-219-0655

male pharmacist

Dr. Young Il Kwon, PHARM.D.


Pharmacist
1700 N Olden Ave, Ewing, NJ 08638
609-896-9089    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.